New Awards for DNA Sequencing
BETHESDA, Md--The National Center for Human Genome Research at the NIH has announced six research grants that are expected to propel forward the final phase of the Human Genome Project, headed by Dr. Francis Collins.
BETHESDA, Md--The National Center for Human Genome Research atthe NIH has announced six research grants that are expected topropel forward the final phase of the Human Genome Project, headedby Dr. Francis Collins.
The grants, ranging from $1 million to $6.7 million a year forup to 3 years, are meant to accelerate the process of automatedDNA sequencing. The recipient institutions are The Institute forGenomic Research; Baylor College of Medicine; the Whitehead Institute-MITGenome Center; Stanford University; University of Washington,Seattle; and Washington University.
A requirement of the awards is that the researchers release theirnew sequencing data quickly to the scientific community, includingreports on a World Wide Web page.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
